Dietary medium-chain triglycerides prevent chemically induced experimental colitis in rats

Area of Science:

• Nutrition Science
• Gastroenterology
• Immunology

Background:

• Experimental colitis is a significant health concern.
• Dietary interventions are explored for managing inflammatory conditions.
• Medium-chain triglycerides (MCTs) possess potential anti-inflammatory properties.

Purpose of the Study:

• To investigate the therapeutic effects of dietary MCTs on chemically induced colitis in a rat model.
• To elucidate the underlying mechanisms of MCTs' action on inflammatory pathways.

Main Methods:

• Rats received intracolonic 2,4,6-trinitrobenzene sulphonic acid (TNBS) to induce colitis.
• Liquid diets with MCTs or corn oil (control) were administered.
• Colitis severity, myeloperoxidase (MPO) activity, inflammatory cytokine/chemokine levels (mRNA and protein), and Toll-like receptor-4 (TLR-4) expression were assessed.
• In vitro studies evaluated MCTs' effect on macrophage inflammatory cytokine production.

Main Results:

• Dietary MCTs significantly attenuated colitis severity and MPO activity.
• MCTs reduced colonic expression of inflammatory mediators including interleukin-1beta (IL-1beta), tumor necrosis factor-alpha (TNF-alpha), and macrophage inflammatory protein-2 (MIP-2).
• MCTs significantly downregulated TLR-4 protein levels in both the colon and macrophages.

Conclusions:

• Dietary MCTs demonstrate significant therapeutic benefits in experimental colitis.
• MCTs exert anti-inflammatory and immunomodulatory effects, likely via TLR-4 pathway modulation.
• MCTs represent a promising nutritional strategy for managing inflammatory bowel disease.